Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 175

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 175
---
 - |     |              | 21,000 | -4 |     |       | 5,013,500 |
|                             |     |      | 2023 |     |        | 195,000 |     |       | - |     |        | - |     |        |         - |     |                | - |     |              | - |     |              |      - |    |     |       |   195,000 |
| Arie Gordashnikov           |     |      | 2024 |     |        |  54,500 |     |       | - |     |        | - |     |        |         - |     |                | - |     |              | - |     |              |      - |    |     |       |    54,500 |
|                             |     |      | 2023 |     |        |  28,000 |     |       | - |     |        | - |     |        |         - |     |                | - |     |              | - |     |              |      - |    |     |       |    28,000 |

| (1) | In accordance with SEC rules, the amounts in this column reflect the fair value on the grant date of the option awards granted to the named executive, calculated in accordance with ASC Topic 718. Stock options were valued using the Black-Scholes model. The grant-date fair value does not necessarily reflect the value of shares which may be received in the future with respect to these awards. The grant-date fair value of the stock options in this column is a non-cash expense for us that reflects the fair value of the stock options on the grant date and therefore does not affect our cash balance. The fair value of the stock options will likely vary from the actual value the holder receives because the actual value depends on the number of options exercised and the market price of our Common Stock on the date of exercise. |

| (2) | David Akunis joined the Company on December 17, 2024 and was appointed Chief Executive Officer effective December 23, 2024. Mr. Akunis resigned from as Chief Executive Officer and from all other positions with the Company on May 21, 2025, |

| (3) | Inna Martin served as Chief Executive Officer from November 2019 through December 22, 2024, whereupon she was appointed as Chief Operating Officer. Inna